Gene therapy in China: From a clinician's perspective.
作者信息
Wang Xiaole, Peng Jing
机构信息
Department of Pediatrics, Xiangya Hospital of Central South University, Changsha, Hunan Province, China.
Department of Pediatrics, Xiangya Hospital of Central South University, Changsha, Hunan Province, China; Clinical Research Center for Children Neurodevelopmental Disabilities of Hunan Province, Changsha, China.
出版信息
Mol Ther. 2025 Jun 4;33(6):2330-2331. doi: 10.1016/j.ymthe.2025.01.018. Epub 2025 Jan 24.
Abstract
摘要
相似文献
1
Gene therapy in China: From a clinician's perspective.
Mol Ther. 2025 Jun 4;33(6):2330-2331. doi: 10.1016/j.ymthe.2025.01.018. Epub 2025 Jan 24.
2
Perceptions, experiences and preferences of patients receiving a clinician's touch during intimate care and procedures: a qualitative systematic review.
JBI Database System Rev Implement Rep. 2017 Nov;15(11):2707-2722. doi: 10.11124/JBISRIR-2017-003375.
3
Changes in ECT services in India since the implementation of its mental health care act 2017: a clinician's perspective.
BMC Psychiatry. 2025 Jul 1;25(1):670. doi: 10.1186/s12888-025-07109-3.
4
Relationship Between Gender and Clinician's Subjective Experience during the Interaction with Psychiatric Patients.
Clin Pract Epidemiol Ment Health. 2021 Dec 22;17:190-197. doi: 10.2174/1745017902117010190. eCollection 2021.
5
To use or not to use corticosteroids for pneumonia? A clinician's perspective.
Monaldi Arch Chest Dis. 2012 Jun;77(2):94-101. doi: 10.4081/monaldi.2012.157.
6
Clinician's Subjective Experience in the Cross-Cultural Psychiatric Encounter.
Psychopathology. 2020;53(5-6):282-290. doi: 10.1159/000509489. Epub 2020 Sep 3.
7
Behind the screen: exploring the effects of home working on 999 telephone clinicians during the COVID-19 pandemic.
Br Paramed J. 2024 Sep 1;9(2):1-10. doi: 10.29045/14784726.2024.9.9.2.1.
8
The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
J Patient Rep Outcomes. 2024 Jan 4;8(1):2. doi: 10.1186/s41687-023-00679-4.
9
The Initial Treatment Plan Versus the Actually Performed Treatment of Patients With Temporomandibular Disorders in the First 6 Months After the Initial Visit.
J Oral Rehabil. 2025 Jul 1. doi: 10.1111/joor.70012.
10
Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples.
Ann Pharmacother. 2009 Sep;43(9):1496-505. doi: 10.1345/aph.1M211. Epub 2009 Aug 18.
本文引用的文献
1
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution.
Med Res Rev. 2024 Sep;44(5):2112-2193. doi: 10.1002/med.22036. Epub 2024 Mar 28.
2
Adeno-associated virus vector as a platform for gene therapy delivery.
Nat Rev Drug Discov. 2019 May;18(5):358-378. doi: 10.1038/s41573-019-0012-9.
3
Gene therapy comes of age.
Science. 2018 Jan 12;359(6372). doi: 10.1126/science.aan4672.
4
Gendicine: the first commercial gene therapy product.
Hum Gene Ther. 2005 Sep;16(9):1014-5. doi: 10.1089/hum.2005.16.1014.
5
Stage I clinical trial of gene therapy for hemophilia B.
Sci China B. 1993 Nov;36(11):1342-51.
6
Gene therapy for human genetic disease?
Science. 1972 Mar 3;175(4025):949-55. doi: 10.1126/science.175.4025.949.
Zotero 插件